Roche-1 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Roche’s Rituxan outperforms MMF in pemphigus vulgaris study

Roche-1
Roche announces data from the Phase III PEMPHIX study evaluating the efficacy and safety of rituximab compared to MMF in adults with moderate to severe PV. Credit: F. Hoffmann-La Roche Ltd.